What is Edgewise Therapeutics, Inc.'s investing cash flow?

Edgewise Therapeutics, Inc. (EWTX) reported investing cash flow of $2.43M in Q1 2026.

How has Edgewise Therapeutics, Inc.'s investing cash flow changed year-over-year?

Edgewise Therapeutics, Inc.'s investing cash flow decreased by 94.5% year-over-year, from $43.9M to $2.43M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Edgewise Therapeutics, Inc. EWTX Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

CytokineticsCYTK

$145.49M+37.3%

PTC TherapeuticsPTCT

-$93.74M+49.2%

Catalyst PharmaceuticalCPRX

-$27K—

Dyne Therapeutics, Inc.DYN

-$2.39M-264%

Viking TherapeuticsVKTX

$54.19M-14.3%

Other financials

Income statement

See full

Operating income-$54.1M-17.7%

Net income-$49.0M-20.1%

EPS (diluted)-$0.46-7.0%

Balance sheet

See full

Cash & equivalents$33.2M-33.5%

Total debt$3.8M-16.8%

Total equity$493.2M+14.8%

Total assets$518.5M+14.1%

Cash flow

See full

Operating cash flow-$42.5M-12.4%

CapEx$260.0K+491%

Free cash flow-$42.8M-12.9%

Valuation

See full

Market cap$3.96B+61.3%

Enterprise value$3.93B+63.5%

Returns & leverage

See full

Return on equity-38.1%+13.4pp

Debt / equity0×0.0×

Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s investing cash flow?: Edgewise Therapeutics, Inc. (EWTX) reported investing cash flow of $2.43M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s investing cash flow changed year-over-year?: Edgewise Therapeutics, Inc.'s investing cash flow decreased by 94.5% year-over-year, from $43.9M to $2.43M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.